Back to Search

LFVN

Lifevantage Corporation Common Stock (Delaware)
Data: 2026-06-24
$6.16
Price
-0.32%
Change
$15.00
52W High
$3.90
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Quick Stats
Jun 24, 2026

55.0

AI Score

HOLD

0.08

Volume Ratio

Sep 03, 2026

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

LFVN Stock Summary

Last updated

LFVN is currently trading at $6.16, positioned below its 200-day moving average of $6.62, suggesting bearish momentum. The stock has a 52-week range of $3.9 to $15.

Technical Analysis: The 50-day moving average stands at $6.33, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LFVN at 55.0/100 with a HOLD recommendation.

LFVN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LFVN Price vs Max Options Open Interest
LFVN Max Change In Options Open Interest

LFVN Options - Sort by Max open Interest (near term)

24th June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LFVN Daily Out of Money Options - Sort by Max open Interest (near term)

24th June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LFVN Daily In the Money Options - Sort by Max open Interest (near term)

24th June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LFVN Most Active Options by Volume(near term)

24th June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Lifevantage Corporation Common Stock (Delaware) is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

LFVN Moving Averages Analysis

LFVN (Lifevantage Corporation Common Stock (Delaware)) Simple Moving Averages

Moving Averages are last updated Jun 24, 2026

Days MA
10 7.16
20 8.05
30 7.18
50 6.33
100 5.53
200 6.62

LFVN Fundamental Analysis

P/E (Forward) 37.4532
P/E (Trailing) 13.5111
Market Cap ($) 76.7 million
Earnings/Share ($) 0.45
Net Proft Margin (%) 0.0295
Dividend/Share ($) 0.18
EPS Estimate Current Year ($) 0.5733
EPS Estimate Next Year ($) 0.4567
WallStreet Target Price ($) 7
Most Recent Quarter